Search research articles
Contact Us
Filters
Showing results (1-10 of 173) with videos related to
Page
of 18
Sort By:
Agents and Actions. Supplements
|
January 1, 1986
Modifications of platelet functional and biochemical parameters in human type IIa hypercholesterolemia
R Paoletti, E Tremoli
Thrombosis and Haemostasis
|
April 8, 1988
Dipyridamole inhibits superoxide anion generation by human neutrophils
E Tremoli, S Colli
The Journal of Laboratory and Clinical Medicine
|
August 1, 1991
Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms
S Colli, E Tremoli
Journal of Thrombosis and Haemostasis : JTH
|
November 25, 2003
Modulation of adhesion molecule expression on endothelial cells: to be or not to be?
P L Meroni, E Tremoli
Agents and Actions. Supplements
|
January 1, 1984
Oral administration of polyunsaturated phosphatidylcholine reduces lipid and cholesterol contents in platelets of healthy volunteers
C Galli, E Tremoli, C Sirtori
Minerva Endocrinologica
|
July 2, 2002
[PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms]
C Banfi, L Mussoni, E Tremoli
Journal of Cardiovascular Pharmacology
|
January 1, 1985
Pathological significance of the thromboxane-prostacyclin hypothesis
R Paoletti, P Maderna, E Tremoli
Thrombosis Research. Supplement
|
January 1, 1990
Mode of action of PGI2 and of its stable derivative iloprost on platelets and leukocytes
E Tremoli, S Colli, R Paoletti
Advances in Experimental Medicine and Biology
|
January 1, 1984
GYKI 14,451, a synthetic tripeptide inhibitor of thrombin: "in vitro" and "in vivo" studies
E Tremoli, S Colli, R Paoletti
Thrombosis Research
|
October 15, 1988
Effects of aggregating agents and of blood cells on the aggregation of whole blood by impedance technique
L Mannucci, R Redaelli, E Tremoli
Page
of 18
Search research articles
Search
Showing results (1-10 of 173) with videos related to
Sort By:
Page
of 18
Agents and Actions. Supplements
|
January 1, 1986
Modifications of platelet functional and biochemical parameters in human type IIa hypercholesterolemia
R Paoletti, E Tremoli
Thrombosis and Haemostasis
|
April 8, 1988
Dipyridamole inhibits superoxide anion generation by human neutrophils
E Tremoli, S Colli
The Journal of Laboratory and Clinical Medicine
|
August 1, 1991
Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms
S Colli, E Tremoli
Journal of Thrombosis and Haemostasis : JTH
|
November 25, 2003
Modulation of adhesion molecule expression on endothelial cells: to be or not to be?
P L Meroni, E Tremoli
Agents and Actions. Supplements
|
January 1, 1984
Oral administration of polyunsaturated phosphatidylcholine reduces lipid and cholesterol contents in platelets of healthy volunteers
C Galli, E Tremoli, C Sirtori
Minerva Endocrinologica
|
July 2, 2002
[PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms]
C Banfi, L Mussoni, E Tremoli
Journal of Cardiovascular Pharmacology
|
January 1, 1985
Pathological significance of the thromboxane-prostacyclin hypothesis
R Paoletti, P Maderna, E Tremoli
Thrombosis Research. Supplement
|
January 1, 1990
Mode of action of PGI2 and of its stable derivative iloprost on platelets and leukocytes
E Tremoli, S Colli, R Paoletti
Advances in Experimental Medicine and Biology
|
January 1, 1984
GYKI 14,451, a synthetic tripeptide inhibitor of thrombin: "in vitro" and "in vivo" studies
E Tremoli, S Colli, R Paoletti
Thrombosis Research
|
October 15, 1988
Effects of aggregating agents and of blood cells on the aggregation of whole blood by impedance technique
L Mannucci, R Redaelli, E Tremoli
Page
of 18